Topotecan inhibits VEGF‐ and bFGF‐induced vascular endothelial cell migration via downregulation of the PI3K‐Akt signaling pathway

Ayako Nakashio(GlaxoSmithKline (Japan)), Takashi Tsuruo(Japanese Foundation For Cancer Research)
International Journal of Cancer
December 18, 2001
Cited by 93


Related Papers